Herbas VPB

Print
EN | LT
LT - BIOMARKERS FOR PREDICTING AND ASSESSING RESPONSIVENESS OF ENDOMETRIAL CANCER SUBJECTS TO LENVATINIB COMPOUNDS
EN - BIOMARKERS FOR PREDICTING AND ASSESSING RESPONSIVENESS OF ENDOMETRIAL CANCER SUBJECTS TO LENVATINIB COMPOUNDS

Legal status

Patent not validated

Bibliographic data
Indications of the International Patent Classification (IPC)
(51) INT.CL. G01N 33/574
European patent
(11) Number of the document 2997377
(13) Kind of document T
(96) European patent application number 14727633.1
Date of filing the European patent application 2014-05-12
(97) Date of publication of the European application 2016-03-23
(45) Date of publication and mention of the grant of the patent 2018-07-18
(46) Date of publication of the claims translation
PCT application
(86) Number PCT/JP2014/063134
Date 2014-05-12
PCT application publication
(87) Number WO 2014/185540
Date 2014-11-20
Priority applications
(30) Number Date Country code
201361823034 P 2013-05-14 US
Inventors
(72)
FUNAHASHI, Yasuhiro, JP
KADOWAKI, Tadashi, JP
SACHDEV, Pallavi, US
Grantee
(73) Eisai R&D Management Co., Ltd., 4-6-10 Koishikawa Bunkyo-ku, Tokyo 112-8088, JP
Title
(54) BIOMARKERS FOR PREDICTING AND ASSESSING RESPONSIVENESS OF ENDOMETRIAL CANCER SUBJECTS TO LENVATINIB COMPOUNDS
  BIOMARKERS FOR PREDICTING AND ASSESSING RESPONSIVENESS OF ENDOMETRIAL CANCER SUBJECTS TO LENVATINIB COMPOUNDS